States file antitrust complaint against Reckitt Benckiser over Suboxone
MLex Summary: A group of 35 states and the District of Columbia filed an antitrust complaint accusing Reckitt Benckiser of unlawfully monopolizing the market for generic versions of the opioid addiction...To view the full article, register now.
Already a subscriber? Click here to view full article